FBLG
FibroBiologics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.81
+2.56%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+79.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 23, 2026 | Hoffman Robert E. · director | A-Award | 30,803 | $0.75 |
| Jun 23, 2026 | Niklas Victoria Ninon Olivia · director | A-Award | 30,803 | $0.75 |
| Jun 23, 2026 | Link Matthew · director | A-Award | 30,803 | $0.75 |
| Jun 23, 2026 | Cilento Richard C. Jr. · director | A-Award | 30,803 | $0.75 |
| May 4, 2026 | Khoja Hamid · officer: Chief Scientific Officer | A-Award | 61,607 | $1.38 |
| May 4, 2026 | GARCIA RUBEN A · officer: General Counsel | A-Award | 61,607 | $1.38 |
| May 4, 2026 | Davis Jason · officer: Chief Financial Officer | A-Award | 61,607 | $1.38 |
| May 4, 2026 | O'HEERON PETE · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 92,410 | $1.38 |
| Mar 5, 2026 | Khoja Hamid · officer: Chief Scientific Officer | Purchase | 30,000 | $0.38 |
| Mar 4, 2026 | O'HEERON PETE · director, officer: CHIEF EXECUTIVE OFFICER | Purchase | 15,872 | $0.38 |
| Mar 4, 2026 | O'HEERON PETE · director, officer: CHIEF EXECUTIVE OFFICER | Purchase | 17,428 | $0.35 |
| Mar 4, 2026 | O'HEERON PETE · director, officer: CHIEF EXECUTIVE OFFICER | Purchase | 18,200 | $0.41 |
| Mar 2, 2026 | GARCIA RUBEN A · officer: General Counsel | Purchase | 40,000 | $0.33 |
| Dec 12, 2025 | GARCIA RUBEN A · officer: General Counsel | Purchase | 140,000 | $0.34 |
| Jun 12, 2025 | Niklas Victoria Ninon Olivia · director | A-Award | 22,000 | $0.87 |
| Jun 12, 2025 | Link Matthew · director | A-Award | 22,000 | $0.87 |
| Jun 12, 2025 | Hoffman Robert E. · director | A-Award | 22,000 | $0.87 |
| Jun 12, 2025 | Coen Stacy Ann · director | A-Award | 22,000 | $0.87 |
| Jun 12, 2025 | Cilento Richard C. Jr. · director | A-Award | 22,000 | $0.87 |
| Jun 10, 2025 | Davis Jason · officer: Chief Financial Officer | A-Award | 450,000 | $0.94 |
| May 27, 2025 | Khoja Hamid · officer: Chief Scientific Officer | Purchase | 20,000 | $0.84 |
| Mar 28, 2025 | O'HEERON PETE · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 453,000 | $1.04 |
| Mar 28, 2025 | GARCIA RUBEN A · officer: General Counsel | A-Award | 189,000 | $1.04 |
| Mar 28, 2025 | Khoja Hamid · officer: CHIEF SCIENTIFIC OFFICER | A-Award | 189,000 | $1.04 |
| Dec 30, 2024 | GARCIA RUBEN A · officer: General Counsel | A-Award | 176,200 | $2.36 |
| Dec 30, 2024 | O'HEERON PETE · director, officer: Chief Executive Officer | A-Award | 406,339 | $2.36 |
| Dec 30, 2024 | Khoja Hamid · officer: CHIEF SCIENTIFIC OFFICER | A-Award | 176,200 | $2.36 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 0Reduced 13Sold out 18
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 67,665 | May 15, 2026 |
| FUND EVALUATION GROUP, LLC | New Position | 51,794 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 29,609 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 24,647 | May 13, 2026 |
| CASCADE FINANCIAL PARTNERS, LLC | Reduced | 16,428 | May 12, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 15,997 | May 14, 2026 |
| GOLDMAN SACHS GROUP INC | Unchanged | 10,468 | Mar 25, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 6,380 | May 8, 2026 |
| UBS GROUP AG | Reduced | 5,721 | May 5, 2026 |
| NEWEDGE ADVISORS, LLC | Reduced | 845 | Jun 3, 2026 |
| VANGUARD GLOBAL ADVISERS, LLC | New Position | 536 | May 8, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 460 | May 15, 2026 |
| WESTERN WEALTH MANAGEMENT, LLC | New Position | 200 | May 19, 2026 |
| ROYAL BANK OF CANADA | Reduced | 186 | May 15, 2026 |
| ISLAY CAPITAL MANAGEMENT, LLC | Reduced | 169 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 23, 2026